Revolune and Concept Life Sciences Collaborate on Multiplex IF Assays

Revolune has announced a partnership with Concept Life Sciences aiming to assist biopharma and life sciences clients in transitioning multiplex immunofluorescence (IF) assays to new workflows. The collaboration will focus on re-evaluating, transferring, and scaling these assays, leveraging Revolune's technology that now accommodates 4- to 7-plex assays.

This partnership emerges to meet the growing need for adaptable workflows in tissue biomarker research. Concept Life Sciences will provide expertise in assay development and translational biology, facilitating the transition and preserving existing assay strategies.

The partnership is also part of Revolune's broader strategy to build a supportive ecosystem for assay migration, helping research teams maintain scientific value while adopting flexible multiplex platforms.